These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7862640)

  • 41. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
    Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K
    J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185neu DNA vaccination in Her-2/neu transgenic BALB/c mice.
    Di Carlo E; Rovero S; Boggio K; Quaglino E; Amici A; Smorlesi A; Forni G; Musiani P
    Clin Cancer Res; 2001 Mar; 7(3 Suppl):830s-837s. PubMed ID: 11300480
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PDGF-independent activation of PDGF-beta receptors in NIH-3T3 cells transformed by c-met protooncogene.
    Kochhar KS; Linnekin D; Iyer AP
    Exp Cell Res; 1994 Jun; 212(2):414-21. PubMed ID: 7514539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of protein tyrosine phosphatase 1B expression on transformation by the human neu oncogene.
    Brown-Shimer S; Johnson KA; Hill DE; Bruskin AM
    Cancer Res; 1992 Jan; 52(2):478-82. PubMed ID: 1345814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Shc dominant negative disrupts cell cycle progression in both G0-G1 and G2-M of ErbB2-positive breast cancer cells.
    Stevenson LE; Ravichandran KS; Frackelton AR
    Cell Growth Differ; 1999 Jan; 10(1):61-71. PubMed ID: 9950219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HER-2/neu mediates oncogenic transformation via altered CREB expression and function.
    Steven A; Leisz S; Massa C; Iezzi M; Lattanzio R; Lamolinara A; Bukur J; Müller A; Hiebl B; Holzhausen HJ; Seliger B
    Mol Cancer Res; 2013 Nov; 11(11):1462-77. PubMed ID: 24025972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cell cycle-dependent phosphorylation of C/EBPbeta mediates oncogenic cooperativity between C/EBPbeta and H-RasV12.
    Shuman JD; Sebastian T; Kaldis P; Copeland TD; Zhu S; Smart RC; Johnson PF
    Mol Cell Biol; 2004 Sep; 24(17):7380-91. PubMed ID: 15314150
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell cycle-dependent expression of cyclin D1 and a 45 kD protein in human A549 lung carcinoma cells.
    Wu F; Bui KC; Buckley S; Warburton D
    Am J Respir Cell Mol Biol; 1994 Apr; 10(4):437-47. PubMed ID: 8136159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced chemoresistance by elevation of p185neu levels in HER-2/neu-transfected human lung cancer cells.
    Tsai CM; Yu D; Chang KT; Wu LH; Perng RP; Ibrahim NK; Hung MC
    J Natl Cancer Inst; 1995 May; 87(9):682-4. PubMed ID: 7538595
    [No Abstract]   [Full Text] [Related]  

  • 50. Preventive efficacy of receptor class selective retinoids on HER-2/neu oncogene expressing preneoplastic human mammary epithelial cells.
    Jinno H; Steiner MG; Nason-Burchenal K; Osborne MP; Telang NT
    Int J Oncol; 2002 Jul; 21(1):127-34. PubMed ID: 12063559
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distinct tyrosine autophosphorylation sites mediate induction of epithelial mesenchymal like transition by an activated ErbB-2/Neu receptor.
    Khoury H; Dankort DL; Sadekova S; Naujokas MA; Muller WJ; Park M
    Oncogene; 2001 Feb; 20(7):788-99. PubMed ID: 11314013
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cycling in Switzerland.
    Bernards R
    Trends Genet; 1996 Apr; 12(4):158-9. PubMed ID: 8901423
    [No Abstract]   [Full Text] [Related]  

  • 53. The structure of the human cell cycle.
    Stallaert W; Kedziora KM; Taylor CD; Zikry TM; Ranek JS; Sobon HK; Taylor SR; Young CL; Cook JG; Purvis JE
    Cell Syst; 2022 Jan; 13(1):103. PubMed ID: 35051372
    [No Abstract]   [Full Text] [Related]  

  • 54. Controlling tumor-derived and vascular endothelial cell growth: role of the 4Ff2 cell surface antigen.
    Papetti M; Herman IM
    Am J Pathol; 2001 Jul; 159(1):165-78. PubMed ID: 11438464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of the Tat-binding protein 1 gene accompanies the disabling of oncogenic erbB receptor tyrosine kinases.
    Park BW; O'Rourke DM; Wang Q; Davis JG; Post A; Qian X; Greene MI
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6434-8. PubMed ID: 10339605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conversion of a radioresistant phenotype to a more sensitive one by disabling erbB receptor signaling in human cancer cells.
    O'Rourke DM; Kao GD; Singh N; Park BW; Muschel RJ; Wu CJ; Greene MI
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10842-7. PubMed ID: 9724792
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunologic approaches to inhibiting cell-surface-residing oncoproteins in human tumors.
    O'Rourke DM; Greene MI
    Immunol Res; 1998; 17(1-2):179-89. PubMed ID: 9479580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trans receptor inhibition of human glioblastoma cells by erbB family ectodomains.
    O'Rourke DM; Qian X; Zhang HT; Davis JG; Nute E; Meinkoth J; Greene MI
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3250-5. PubMed ID: 9096379
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell cycle-dependent regulation of p185neu: a relationship between disruption of this regulation and transformation.
    Kiyokawa N; Yan DH; Brown ME; Hung MC
    Proc Natl Acad Sci U S A; 1995 Feb; 92(4):1092-6. PubMed ID: 7862640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involvement of cdc2-mediated phosphorylation in the cell cycle-dependent regulation of p185neu.
    Kiyokawa N; Karunagaran D; Lee EK; Xie Y; Yan DH; Hung MC
    Oncogene; 1997 Nov; 15(22):2633-41. PubMed ID: 9400990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.